PT2419108T - Método para contracepção quando necessária - Google Patents
Método para contracepção quando necessáriaInfo
- Publication number
- PT2419108T PT2419108T PT107170847T PT10717084T PT2419108T PT 2419108 T PT2419108 T PT 2419108T PT 107170847 T PT107170847 T PT 107170847T PT 10717084 T PT10717084 T PT 10717084T PT 2419108 T PT2419108 T PT 2419108T
- Authority
- PT
- Portugal
- Prior art keywords
- demand contraception
- contraception
- demand
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Separation By Low-Temperature Treatments (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16914909P | 2009-04-14 | 2009-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2419108T true PT2419108T (pt) | 2016-11-07 |
Family
ID=42309669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT107170847T PT2419108T (pt) | 2009-04-14 | 2010-04-13 | Método para contracepção quando necessária |
Country Status (25)
Country | Link |
---|---|
US (4) | US9616073B2 (pt) |
EP (2) | EP2419108B1 (pt) |
JP (2) | JP5951480B2 (pt) |
CN (1) | CN102395373A (pt) |
AU (1) | AU2010237120B8 (pt) |
BR (1) | BRPI1014035A2 (pt) |
CA (1) | CA2757496A1 (pt) |
CY (1) | CY1118236T1 (pt) |
DK (1) | DK2419108T3 (pt) |
ES (1) | ES2602134T3 (pt) |
HK (1) | HK1232150A1 (pt) |
HR (1) | HRP20161437T1 (pt) |
HU (1) | HUE029434T2 (pt) |
IL (1) | IL215524A0 (pt) |
LT (1) | LT2419108T (pt) |
ME (1) | ME02548B (pt) |
NZ (2) | NZ615430A (pt) |
PL (1) | PL2419108T3 (pt) |
PT (1) | PT2419108T (pt) |
RS (1) | RS55331B1 (pt) |
RU (1) | RU2542779C2 (pt) |
SI (1) | SI2419108T1 (pt) |
SM (1) | SMT201600399B (pt) |
WO (1) | WO2010119029A1 (pt) |
ZA (1) | ZA201107543B (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
EP2419108B1 (en) | 2009-04-14 | 2016-08-17 | Laboratoire HRA Pharma | Method for on-demand contraception |
DE202011110355U1 (de) * | 2011-03-09 | 2014-01-15 | Arstat, Inc. | Behandlung von Uterusmyomen durch intravaginale Verabreichung einer niedrigen Dosis eines selektiven Progesteronrezeptormodulators, eines Antigestagens oder eines Antigestagen-Wirkstoffes |
CN102727457B (zh) * | 2011-04-08 | 2014-05-28 | 华润紫竹药业有限公司 | 稳定的醋酸优力司特制剂 |
FR2987271B1 (fr) | 2012-02-28 | 2017-08-18 | Hra Pharma Lab | Combinaison de modulateurs selectifs du recepteur a la progesterone et d'anti-inflammatoires non steroidiens |
JP2015532263A (ja) | 2012-09-28 | 2015-11-09 | あすか製薬株式会社 | ウリプリスタール酢酸エステルの結晶多形 |
JP6200493B2 (ja) | 2012-09-28 | 2017-09-20 | あすか製薬株式会社 | 無定形ウリプリスタール酢酸エステル |
AU2013321890B2 (en) | 2012-09-28 | 2017-05-18 | Aska Pharmaceutical Co., Ltd. | Crystalline polymorphic form of ulipristal acetate |
FR2997628B1 (fr) | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone |
FR2997627B1 (fr) | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant de l'ulipristal acetate |
CN104797258A (zh) | 2012-11-22 | 2015-07-22 | 拜耳药业股份公司 | 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法 |
FR2999081B1 (fr) | 2012-12-06 | 2015-02-27 | Hra Pharma Lab | Dispersion solide d'un modulateur selectif du recepteur a la progesterone |
CN103006595B (zh) * | 2012-12-25 | 2018-04-06 | 江苏亚邦爱普森药业有限公司 | 制备醋酸优力司特片的方法 |
JP6370887B2 (ja) | 2013-05-23 | 2018-08-08 | バイエル・ファルマ・アクティエンゲゼルシャフト | オンデマンド避妊のための医薬組成物およびその使用、ならびにこの医薬組成物の適用体制 |
FR3060389B1 (fr) | 2016-12-20 | 2019-05-31 | Laboratoire Hra-Pharma | Comprime enrobe comprenant de l'ulipristal acetate ou un de ses metabolites |
WO2017216637A2 (en) | 2017-08-04 | 2017-12-21 | Alvogen Malta Operations (Row) Ltd | Tablet form including ulipristal acetate and the methods for its preparation |
WO2019204163A1 (en) | 2018-04-20 | 2019-10-24 | Tessenderlo Kerley, Inc. | Liquid nitrogen fertilizer compositions and additives therefore |
EP3575278A1 (en) | 2018-05-31 | 2019-12-04 | Tessenderlo Kerley, Inc. | Liquid nitrogen fertilizer compositions and additives therefor |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6A (en) * | 1836-08-10 | Thomas blanghard | ||
DE1922005A1 (de) | 1969-04-24 | 1970-11-05 | Schering Ag | Mittel und Methode zur Kontrazeption |
US4954490A (en) | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
DE4405898A1 (de) | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
ES2279515T3 (es) | 1994-10-24 | 2007-08-16 | Bayer Schering Pharma Aktiengesellschaft | Antagonistas competitivos de la progesterona para el control de la fertilidad femenina, orientado a las necesidades de uso. |
US5929262A (en) | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
EP1098653A2 (en) * | 1998-07-17 | 2001-05-16 | PHARMACIA & UPJOHN COMPANY | Subcutaneous medroxyprogesterone acetate for contraception |
AU5619399A (en) * | 1998-08-11 | 2000-03-06 | Akzo Nobel N.V. | Progestogen-only contraceptive kit providing good cycle control |
IL148415A0 (en) | 1999-08-31 | 2002-09-12 | Jenapharm Gmbh | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
ES2546291T3 (es) * | 2000-03-17 | 2015-09-22 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | 17-Alfa-sustituida, 11-beta-sustituida-4-arilo y 21-sustituida 19-norpregnadienodionas como agentes antiprogestacionales |
HU227198B1 (en) | 2001-11-27 | 2010-10-28 | Richter Gedeon Nyrt | Pharmaceutical composition for emergency contraception containing levonorgestrel |
ES2212912B1 (es) * | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
AU2004217988C1 (en) | 2003-02-28 | 2010-06-03 | Southwest Foundation For Biomedical Research | Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
GT200500186A (es) | 2004-07-07 | 2006-03-02 | Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits | |
CN1980660A (zh) * | 2004-07-07 | 2007-06-13 | 惠氏公司 | 孕酮受体拮抗剂的避孕方案和试剂盒 |
CA2573266C (en) | 2004-07-09 | 2011-11-08 | The Population Council, Inc. | Sustained release compositions containing progesterone receptor modulators |
CA2623678A1 (en) | 2005-09-29 | 2007-04-05 | Repros Therapeutics Inc. | Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride |
DE102005050729A1 (de) | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
US7867515B2 (en) * | 2006-12-20 | 2011-01-11 | TEVA Woman's Health, Inc. | Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
MX2009006912A (es) | 2006-12-28 | 2009-08-12 | Repros Therapeutics Inc | Metodos y formulaciones para biodisponibilidad mejorada de antiprogestinas. |
CN101720321B (zh) * | 2007-03-07 | 2012-12-05 | 詹森药业有限公司 | 作为选择性受体调节剂的甾族衍生物 |
UY31010A1 (es) * | 2007-04-05 | 2008-11-28 | Bayer Schering Pharma Ag | Nuevo régimen de drospirenona/17b-estradiol, producto farmacéutico combinado y conjunto de elementos (kit) para su aplicacion |
AU2008341138A1 (en) * | 2007-12-20 | 2009-07-02 | Teva Women's Health, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
US8512745B2 (en) | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
US9180131B2 (en) | 2008-12-12 | 2015-11-10 | Laboratoire Hra Pharma | Method for contraception |
EP2419108B1 (en) | 2009-04-14 | 2016-08-17 | Laboratoire HRA Pharma | Method for on-demand contraception |
-
2010
- 2010-04-13 EP EP10717084.7A patent/EP2419108B1/en not_active Revoked
- 2010-04-13 AU AU2010237120A patent/AU2010237120B8/en active Active
- 2010-04-13 ME MEP-2016-239A patent/ME02548B/me unknown
- 2010-04-13 RU RU2011146058/14A patent/RU2542779C2/ru not_active IP Right Cessation
- 2010-04-13 LT LTEP10717084.7T patent/LT2419108T/lt unknown
- 2010-04-13 NZ NZ615430A patent/NZ615430A/en unknown
- 2010-04-13 PT PT107170847T patent/PT2419108T/pt unknown
- 2010-04-13 HU HUE10717084A patent/HUE029434T2/en unknown
- 2010-04-13 WO PCT/EP2010/054812 patent/WO2010119029A1/en active Application Filing
- 2010-04-13 ES ES10717084.7T patent/ES2602134T3/es active Active
- 2010-04-13 US US13/263,717 patent/US9616073B2/en active Active
- 2010-04-13 PL PL10717084T patent/PL2419108T3/pl unknown
- 2010-04-13 NZ NZ595790A patent/NZ595790A/xx unknown
- 2010-04-13 CN CN2010800163136A patent/CN102395373A/zh active Pending
- 2010-04-13 JP JP2012505146A patent/JP5951480B2/ja active Active
- 2010-04-13 DK DK10717084.7T patent/DK2419108T3/en active
- 2010-04-13 RS RS20160950A patent/RS55331B1/sr unknown
- 2010-04-13 EP EP16181168.2A patent/EP3106167A1/en not_active Withdrawn
- 2010-04-13 CA CA2757496A patent/CA2757496A1/en not_active Abandoned
- 2010-04-13 SI SI201031306T patent/SI2419108T1/sl unknown
- 2010-04-13 BR BRPI1014035A patent/BRPI1014035A2/pt not_active Application Discontinuation
-
2011
- 2011-10-04 IL IL215524A patent/IL215524A0/en unknown
- 2011-10-14 ZA ZA2011/07543A patent/ZA201107543B/en unknown
-
2015
- 2015-03-02 US US14/635,107 patent/US9283233B2/en active Active
-
2016
- 2016-02-05 US US15/016,845 patent/US10159681B2/en active Active
- 2016-06-08 JP JP2016114491A patent/JP2016188232A/ja active Pending
- 2016-11-01 CY CY20161101108T patent/CY1118236T1/el unknown
- 2016-11-02 HR HRP20161437TT patent/HRP20161437T1/hr unknown
- 2016-11-08 SM SM201600399T patent/SMT201600399B/it unknown
-
2017
- 2017-06-14 HK HK17105890.1A patent/HK1232150A1/zh unknown
-
2018
- 2018-12-21 US US16/230,802 patent/US10772897B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1232150A1 (zh) | 按需避孕方法 | |
ZA202006532B (en) | Method for decreasing immunogenicity | |
GB0905140D0 (en) | Method | |
GB0911905D0 (en) | Method | |
GB0902476D0 (en) | Method | |
GB0910707D0 (en) | Method | |
GB0913525D0 (en) | Method | |
EP2474560A4 (en) | METHOD OF PREPARING AN 11 SUGAR SIALYLOLIGOSACCHARIDE PEPTIDE | |
GB0913433D0 (en) | Method | |
GB0901444D0 (en) | Method | |
PL2440510T3 (pl) | Sposób wytwarzania pentafluoropropanu | |
IL214287A0 (en) | Method for producing 2-aminobiphenylene | |
GB0905367D0 (en) | Method | |
GB0903316D0 (en) | Method | |
GB0908770D0 (en) | Method | |
PL2446196T3 (pl) | Sposób dostarczania ciepła | |
GB0916013D0 (en) | Method | |
GB0902034D0 (en) | Method | |
GB0900560D0 (en) | Method | |
EP2420492A4 (en) | PROCESS FOR PREPARING 2-HALOGEN-6-SUBSTITUTED 4-TRIFLUOROMETHYLPYRIDINE | |
GB0911362D0 (en) | Method | |
GB0904946D0 (en) | Method | |
GB0914702D0 (en) | Method | |
GB0908816D0 (en) | Method | |
GB0911717D0 (en) | Method |